81 related articles for article (PubMed ID: 18294743)
1. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.
Sohn YM; Tandan JB; Yoksan S; Ji M; Ohrr H
Vaccine; 2008 Mar; 26(13):1638-43. PubMed ID: 18294743
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine.
Wijesinghe PR; Abeysinghe MRN; Yoksan S; Yao Y; Zhou B; Zhang L; Fleming JA; Marfin AA; Victor JC
Vaccine; 2016 Nov; 34(48):5923-5928. PubMed ID: 27773472
[TBL] [Abstract][Full Text] [Related]
3. Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV Immunization.
Feroldi E; Boaz M; Yoksan S; Chokephaibulkit K; Thisyakorn U; Pancharoen C; Monfredo C; Bouckenooghe A
J Infect Dis; 2017 Jan; 215(2):221-227. PubMed ID: 27815383
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and risk factors of Japanese encephalitis in Taiwan, 2010-2022.
Hsu JY; Hung CC; Tsou TP; Chen WC
PLoS Negl Trop Dis; 2023 Oct; 17(10):e0011421. PubMed ID: 37782654
[TBL] [Abstract][Full Text] [Related]
5. Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal.
Upreti SR; Janusz KB; Schluter WW; Bichha RP; Shakya G; Biggerstaff BJ; Shrestha MM; Sedai TR; Fischer M; Gibbons RV; Shrestha SK; Hills SL
Am J Trop Med Hyg; 2013 Mar; 88(3):464-8. PubMed ID: 23358643
[TBL] [Abstract][Full Text] [Related]
6. Investigating Nonspecific Effects of the Live-Attenuated Japanese Encephalitis Vaccine on Lower Respiratory Tract Infections in Children Aged 25-35 Months: Retrospective Cohort Study.
Zhan S; Lin H; Yang Y; Chen T; Mao S; Fu C
JMIR Public Health Surveill; 2024 Mar; 10():e53040. PubMed ID: 38498052
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Neutralizing Antibodies against Japanese Encephalitis Virus among Adolescents and Adults in Korea: A Prospective Multicenter Study.
Kwak BO; Kwon YS; Hong YJ; Nahm CH; Jang W; Uh Y; Cho YG; Kim J; Kim M; Kim DH
Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32575597
[TBL] [Abstract][Full Text] [Related]
8. Coverage of Japanese encephalitis routine vaccination among children in Central India.
Tandale BV; Deshmukh PS; Narang R; Qazi MS; Padmaja GV; Deshmukh PR; Raut AV; Narlawar UW; Jha PK; Rajderkar SS;
J Med Virol; 2022 Sep; ():. PubMed ID: 36114690
[TBL] [Abstract][Full Text] [Related]
9. Letter to the Editor Re: Enstrom JE. Fine particulate and total mortality in Cancer Prevention Study cohort reanalysis.
Lipfert FW
Dose Response; 2018; 16(1):1559325817746304. PubMed ID: 29383009
[No Abstract] [Full Text] [Related]
10. Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005-2012.
Liu Y; Lin H; Zhu Q; Wu C; Zhao Z; Zheng H
Vaccine; 2014 Mar; 32(15):1768-73. PubMed ID: 24503272
[TBL] [Abstract][Full Text] [Related]
11. Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.
Ginsburg AS; Meghani A; Halstead SB; Yaich M
Hum Vaccin Immunother; 2017 Oct; 13(10):2222-2231. PubMed ID: 28841362
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults.
Khan SA; Kakati S; Dutta P; Chowdhury P; Borah J; Topno R; Jadhav SM; Mohapatra PK; Mahanta J; Gupte MD
Indian J Med Res; 2016 Dec; 144(6):886-892. PubMed ID: 28474625
[TBL] [Abstract][Full Text] [Related]
13. Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus.
Salem GM; Galula JU; Wu SR; Liu JH; Chen YH; Wang WH; Wang SF; Song CS; Chen FC; Abarientos AB; Chen GW; Wang CI; Chao DY
Commun Biol; 2024 Jan; 7(1):15. PubMed ID: 38267569
[TBL] [Abstract][Full Text] [Related]
14. Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial.
Zaman K; Yunus M; Aziz AB; Feser J; Mooney J; Tang Y; Ellison DW; Thaisomboonsuk B; Zhang L; Neuzil KM; Marfin AA; Letson GW
Vaccine X; 2022 Apr; 10():100143. PubMed ID: 35243320
[TBL] [Abstract][Full Text] [Related]
15. Japanese encephalitis virus live attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity.
Davis EH; Beck AS; Li L; White MM; Greenberg MB; Thompson JK; Widen SG; Barrett ADT; Bourne N
NPJ Vaccines; 2021 Sep; 6(1):112. PubMed ID: 34475404
[TBL] [Abstract][Full Text] [Related]
16. Serological and molecular epidemiology of Japanese Encephalitis in Zhejiang, China, 2015-2018.
Deng X; Yan JY; He HQ; Yan R; Sun Y; Tang XW; Zhou Y; Pan JH; Mao HY; Zhang YJ; Lv HK
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008574. PubMed ID: 32853274
[TBL] [Abstract][Full Text] [Related]
17. Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices.
Hills SL; Walter EB; Atmar RL; Fischer M;
MMWR Recomm Rep; 2019 Jul; 68(2):1-33. PubMed ID: 31518342
[TBL] [Abstract][Full Text] [Related]
18. Twenty Years of Progress Toward West Nile Virus Vaccine Development.
Kaiser JA; Barrett ADT
Viruses; 2019 Sep; 11(9):. PubMed ID: 31491885
[TBL] [Abstract][Full Text] [Related]
19. Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: A case for further catch up campaigns?
Turtle L; Brindle HE; Schluter WW; Faragher B; Rayamajhi A; Bohara R; Gurung S; Shakya G; Yoksan S; Dixit S; Rajbhandari R; Paudel B; Adhikari S; Solomon T; Griffiths MJ
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007269. PubMed ID: 30986252
[TBL] [Abstract][Full Text] [Related]
20. Decreases in Both the Seroprevalence of Serum Antibodies and Seroprotection against Japanese Encephalitis Virus among Vaccinated Children.
Wang R; Xie L; Gao N; Fan D; Chen H; Wang P; Zhou H; An J
Virol Sin; 2019 Jun; 34(3):243-252. PubMed ID: 30911897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
